Inflammatory mediators in demyelinating disorders of the CNS and PNS.
about
Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nervesSilver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells.Lifelong calorie restriction alleviates age-related oxidative damage in peripheral nerves.Microwave & magnetic (M2) proteomics reveals CNS-specific protein expression waves that precede clinical symptoms of experimental autoimmune encephalomyelitis.Gamma interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis.Antioxidants and polyunsaturated fatty acids in multiple sclerosis.Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice.Targeting TNF-alpha receptors for neurotherapeuticsNeuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain".Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control.Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy.Neurotoxicity of cobalt.Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles.Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications.Surface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticles.Nerve growth factor and autoimmune diseases.Mechanisms of immune injury in multiple sclerosis.Localization of interferon-gamma and Ia-antigen in T cell line-mediated experimental autoimmune encephalomyelitis.Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells.Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia.Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis.Nitric oxide synthase expression and enzymatic activity in multiple sclerosis.Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production.Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.Oligodendroglial reaction following spinal cord injury in rat: transient upregulation of MBP mRNA.Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6.Endoneurial edema in sural nerve may indicate recent onset inflammatory neuropathy.The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain-Barré syndrome.Dietary supplement with fermented soybeans, natto, improved the neurobehavioral deficits after sciatic nerve injury in rats.β-1,4-Galactosyltransferase I involved in Schwann cells proliferation and apoptosis induced by tumor necrosis factor-alpha via the activation of MAP kinases signal pathways.Levetiracetam exhibits protective properties on rat Schwann cells in vitro.β-1,4-galactosyltransferase I promotes tumor necrosis factor-α autocrine via the activation of MAP kinase signal pathways in Schwann cells.
P2860
Q28583348-6C34E383-2565-4BD6-ACA1-FD4E2BB8D619Q33659863-562B0318-169F-4AA3-87F0-F1A38B64ADB5Q33879901-701601CF-9B81-4B1D-9615-CB2EC36A2DEDQ34124465-CC563394-66D5-4DC0-89F2-48A8B8A8B3FAQ35298405-DE4AD4FF-265B-434D-9A64-ACD7E12B9A41Q36239170-6E7F6C82-BFE4-4B95-B533-E776FA203736Q36338250-7F7E4775-6A1B-4E06-85B3-FE199B697166Q36953319-A2889437-473B-4105-B0C9-A30E405C8B12Q36990841-478ED55C-08F8-4205-A7DD-1F62B7D818C6Q37160332-96543F61-CFE0-42A3-AA9A-72E08C52209FQ37224656-43C2E857-F302-49B8-9418-A94C02070AD5Q37372314-A4840137-B994-4A84-8197-5AD99DEBBADAQ37897790-179900C1-8E13-4E07-ABB1-D7BE388C2E78Q38174718-BEB33AE6-181B-4324-A1D9-381718071029Q39086482-03A6ED24-B37C-4073-8FEF-55DDC236E2F9Q39391621-42520193-E423-4717-8F95-86219FBDC4D3Q40540330-D4D5E4D2-F549-44B5-9298-A5FF0D028A66Q41157659-6209FC23-231A-4CA5-833C-0A75815B32D7Q41552175-C4AC85D7-98AD-4164-8A1A-045C0CF0EF70Q41974481-6BD0F17E-C8DE-4FEF-A282-C09B396858EEQ42575209-533A8B55-EF8F-4F7D-9973-1C2A36528FDEQ43247720-04B821DB-3C82-4102-A336-FE1CF0C57F67Q44796477-4C0CC52F-223A-4D09-BF7F-A1DAF8961365Q46333503-85EA4E80-4736-46B5-A3E4-1A817C0E29C4Q46388109-0507E9FA-B249-4CE6-AF7E-816D67279463Q47294316-A3C6A954-FFCF-415F-A868-F9A29EED2711Q47951617-A8ACEDEE-02C5-48DC-88EC-00481E5A2354Q48363883-54B6B324-4C15-47D0-80B5-06E29494DC23Q48583094-85886AA1-4962-4F9B-B02F-5A22C93410E5Q49690314-BD1A163A-DF65-4CB2-A3F1-7ED162854C6EQ51753209-1F928053-E79D-4524-B413-515C162D9B92Q53657600-300DB24A-99D1-46CF-BAA8-BDA6F8E26D41Q54343673-82D72465-423D-4A43-ABDC-BBBC5AE40F7FQ54599147-C516B786-6CA4-4B63-9022-12026D6B0913
P2860
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
@ast
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
@en
type
label
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
@ast
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
@en
prefLabel
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
@ast
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
@en
P2093
P1476
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
@en
P2093
P304
P356
10.1016/0165-5728(92)90134-7
P577
1992-10-01T00:00:00Z